ATP13A2 Antibody
-
货号:CSB-PA23379A0Rb
-
规格:¥440
-
促销:
-
图片:
-
Immunofluorescence staining of A549 cells with CSB-PA23379A0Rb at 1:133, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4°C. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).
-
-
其他:
产品详情
-
产品名称:Rabbit anti-Homo sapiens (Human) ATP13A2 Polyclonal antibody
-
Uniprot No.:Q9NQ11
-
基因名:ATP13A2
-
别名:AT132_HUMAN antibody; Atp13a2 antibody; ATPase type 13A2 antibody; CLN12 antibody; FLJ26510 antibody; HSA9947 antibody; KRPPD antibody; PARK9 antibody; Probable cation transporting ATPase 13A2 antibody; Probable cation-transporting ATPase 13A2 antibody; Putative ATPase antibody; RP1-37C10.4 antibody
-
宿主:Rabbit
-
反应种属:Human
-
免疫原:Recombinant Human Cation-transporting ATPase 13A2 protein (582-736AA)
-
免疫原种属:Homo sapiens (Human)
-
标记方式:Non-conjugated
本页面中的产品,ATP13A2 Antibody (CSB-PA23379A0Rb),的标记方式是Non-conjugated。对于ATP13A2 Antibody,我们还提供其他标记。见下表:
-
克隆类型:Polyclonal
-
抗体亚型:IgG
-
纯化方式:>95%, Protein G purified
-
浓度:It differs from different batches. Please contact us to confirm it.
-
保存缓冲液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 -
产品提供形式:Liquid
-
应用范围:ELISA, IF
-
推荐稀释比:
Application Recommended Dilution IF 1:50-1:200 -
Protocols:
-
储存条件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
货期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
相关产品
靶点详情
-
功能:ATPase which acts as a lysosomal polyamine exporter with high affinity for spermine. Also stimulates cellular uptake of polyamines and protects against polyamine toxicity. Plays a role in intracellular cation homeostasis and the maintenance of neuronal integrity. Contributes to cellular zinc homeostasis. Confers cellular protection against Mn(2+) and Zn(2+) toxicity and mitochondrial stress. Required for proper lysosomal and mitochondrial maintenance. Regulates the autophagy-lysosome pathway through the control of SYT11 expression at both transcriptional and post-translational levels. Facilitates recruitment of deacetylase HDAC6 to lysosomes to deacetylate CTTN, leading to actin polymerization, promotion of autophagosome-lysosome fusion and completion of autophagy. Promotes secretion of exosomes as well as secretion of SCNA via exosomes. Plays a role in lipid homeostasis.
-
基因功能参考文献:
- This study showed that Lysosomal defects in ATP13A2 associated familial Parkinson's disease. PMID: 28894968
- Hereditary Parkinsonism-associated genetic variations in PARK9 locus lead to functional impairment in the ion transport function of this protein. (Review) PMID: 26965689
- Study unravels a novel activity-independent scaffolding role of ATP13A2 in trafficking/export of intracellular cargo in response to proteotoxic stress. PMID: 28334751
- we describe, for the first time, the deleterious effect arising from the interaction between the ATP13A2 familial mutant Dup22 with a-Syn. We show that this ATP13A2 mutant can enhance a-Syn oligomerization and aggregation in cell culture PMID: 27282395
- ATP13A2 inhibition by hsa-miR-4306 efficiently restored manganese-induced cytotoxicity in cultured neurons. PMID: 28302480
- This study demonstrated that loss of ATP13A2 function causes a combination of lysosomal and mitochondrial dysfunction that affects multiple neuronal populations. PMID: 28137957
- The ATP13A2 A746T variant is rare in Han Chinese patients and controls and is not associated with PD susceptibility in this ethnic group. PMID: 26000924
- This study showed that LRRK2, PARK2 and ATP13A2 are under copy number variations influence in patient with Parkinson disease. PMID: 27399248
- tre results of this study suggests that the expression of ATP13A2 regulated by the PHD2-HIF1alpha signaling pathway,and this is instrumental in maintaining cellular iron homeostasis and cell viability in mitochondrially compromised DAergic neurons. PMID: 26818499
- that ATP13A2 contains a unique N-terminal hydrophobic extension that lies on the cytosolic membrane surface of the lysosome, where it interacts with the lysosomal signaling lipids phosphatidic acid and phosphatidylinositol(3,5)bisphosphate. PMID: 26134396
- ATP13A2 overexpression improves the lysosome membrane integrity and protects against iron-induced cell damage. PMID: 25912790
- A review of recent advances in the emerging association of ATP13A2 mutations with Parkinsonism and neuronal ceroid lipofuscinoses. PMID: 25197640
- The mutation rates of Thr12Met and Ala1144Thr of ATP13A2 in the Uygur and Han Parkinson's disease patients in the Xinjiang region are low. PMID: 25374329
- This study demonistrated that loss of ATP13A2 causes a specific protein trafficking defect, and that Atp13a2 null mice develop age-related motor dysfunction that is preceded by neuropathological changes. PMID: 25855184
- Data show that patients with Lewy body diseases have an overall deficit in ATP13A2 protein levels, with the remaining protein being more insoluble and partially redistributing towards Lewy bodies PMID: 24252509
- Present results of homozygosity mapping in two siblings affected with early onset Parkinson's disease (EOPD) and mutation screening of ATP13A2. The variation identified represents the 13th known disease causing mutation in ATP13A2. PMID: 24949580
- these data suggest the involvement of PARK9 in the biogenesis of exosomes and alpha-synuclein secretion. PMID: 25392495
- Reduced ATP13A2 expression significantly decreased vesicular zinc levels, indicating ATP13A2 facilitates transport of zinc. PMID: 24603074
- human ATP13A2 deficiency results in zinc dyshomeostasis and mitochondrial dysfunction. PMID: 24399444
- PARK9 loss of function leads to dyshomeostasis of intracellular Zn(2+) that in turn contributes to lysosomal dysfunction and accumulation of alpha-Syn. PMID: 24334770
- No association is found between ATP13A2 Ala746Thr and early onset Parkinson's disease (EOPD) or late onset Parkinson's in a Chinese cohort; this variant is not a strong risk factor in the Chinese population. PMID: 23522931
- hypoxia signaling plays a very important role in the regulation of human ATP13A2 gene expression PMID: 22288903
- a novel frame-shift mutation in exon 22 of ATP13A2 (c.2473C>AA, p.Leu825AsnfsX32). PMID: 21696388
- Mutations in ATP13A2 is often associated with rapidly progressive parkinsonism and with additional features including pyramidal signs, cognitive decline and loss of sustained Levodopa responsiveness. PMID: 23196729
- Cathepsin D activity was decreased in ATP13A2-knockdown cells that displayed lysosome-like bodies characterized by fingerprint-like structures PMID: 23499937
- ATP13A2 knockout exacerbates apoptosis and autophagy in infarct penumbra of cerebral cortex, with no influence on the infarct size in mice with ischemic stroke. PMID: 23121889
- ATP13A2 protects against manganese & nickel toxicity, & proteasomal, mitochondrial, & oxidative stress. ATP13A2 may import a cofactor required for the function of a lysosome enzyme(s). PMID: 22847264
- the human P5B-ATPase ATP13A2 is involved in polyamine uptake. PMID: 23205587
- ATP13A2 variation may be a risk marker for neurotoxic effects of manganese in humans. PMID: 22285144
- ATP13A2 and alpha-syn are functionally linked in neurodegeneration. PMID: 22645275
- Our results indicate that ATP13A2 mutations are a rare cause of both NBIA and dystonia-parkinsonism. PMID: 22743658
- This study provides support for common loss-of-function effects of homozygous and heterozygous missense mutations in ATP13A2 associated with early-onset forms of parkinsonism. PMID: 22768177
- The altered apoptotic pattern of subjects with mutated ATP13A2 suggests a correlation between apoptosis alteration and the mutated ATP13A2 protein PMID: 22117566
- These findings collectively suggest that ATP13A2 contributes to the maintenance of a healthy mitochondrial pool, supporting the hypothesis that impaired mitochondrial clearance represents an important pathogenic mechanism underlying KRS. PMID: 22296644
- Data show that a family with typical neuronal ceroid lipofuscinoses (NCLs) pathology carried a single homozygous mutation in ATP13A2 that fully segregates with disease. PMID: 22388936
- This study demonistrated that contralateral silent period duration was increased in the symptomatic ATP13A2 mutation carriers suggested that compound heterozygous mutation in the ATP13A2 gene is associated with increased intracortical inhibition. PMID: 22104014
- results unravel an instrumental role of ATP13A2 deficiency on lysosomal function and cell viability and demonstrate the feasibility and therapeutic potential of modulating ATP13A2 levels in the context of PD PMID: 22647602
- results confirm a role for Ypk9 in manganese homeostasis and illuminates cellular pathways and biological processes in which Ypk9 likely functions PMID: 22457822
- The SNPs investigated in the BST1, PARK15 and PARK9 genes associated with PD susceptibility are not associated with PD in the northern Han Chinese population. PMID: 22490479
- study reveals a number of intriguing neuronal phenotypes due to the loss- or gain-of-function of ATP13A2 that support a role for this protein in regulating intracellular cation homeostasis and neuronal integrity PMID: 22186024
- This study demonistrated that restoration of ATP13A2 function may lead to improved lysosomal function and decreased accumulation of alpha-syn. PMID: 22442086
- rare variants of ATP13A2 may contribute to Parkinson's disease susceptibility in Taiwan PMID: 21714071
- Mutant Atp13a2 proteins are degraded by endoplasmic reticulum-associated degradation and sensitize cells to cell death. PMID: 21665991
- A novel frameshift mutation in ATP13A2 causes juvenile dystonia-parkinsonism and dementia. PMID: 21094623
- premature degradation of mutant ATP13A2 mRNA contribute to the aetiology of Kufor-Rakeb syndrome (KRS). PMID: 21542062
- Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein. PMID: 21724849
- To see if ATP13A2 mutations could be responsible for some cases of human adult-onset NCL (Kufs disease), we resequenced ATP13A2 from 28 Kufs disease patients. None of these patients had ATP13A2 sequence variants likely to be causal for their disease PMID: 21362476
- No clearly pathogenic mutations are identified in ATP13A2 and GIGYF2 in Brazilian patients with early-onset Parkinson's disease. PMID: 20816920
- report clinical, instrumental, and genetic findings in an Italian family with novel PARK9 and PARK15 mutations PMID: 20853184
- We found no evidence for a correlation between a single heterozygous mutation in the ATP13a2 gene and the development of distinct oculomotor disturbances. PMID: 20842691
显示更多
收起更多
-
相关疾病:Kufor-Rakeb syndrome (KRS); Spastic paraplegia 78, autosomal recessive (SPG78)
-
亚细胞定位:Lysosome membrane; Multi-pass membrane protein. Late endosome membrane; Multi-pass membrane protein. Endosome, multivesicular body membrane; Multi-pass membrane protein. Cytoplasmic vesicle, autophagosome membrane; Multi-pass membrane protein.
-
蛋白家族:Cation transport ATPase (P-type) (TC 3.A.3) family, Type V subfamily
-
组织特异性:Expressed in brain; protein levels are markedly increased in brain from subjects with Parkinson disease and subjects with dementia with Lewy bodies. Detected in pyramidal neurons located throughout the cingulate cortex (at protein level). In the substanti
-
数据库链接:
HGNC: 30213
OMIM: 606693
KEGG: hsa:23400
STRING: 9606.ENSP00000327214
UniGene: Hs.128866
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-